Literature DB >> 33418959

Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory Papillomatosis.

Mary C Bedard1, Marion G Brusadelli2, Adrean Carlile1, Sonya Ruiz-Torres1, Hannah Lodin3, Denis Lee4, Matthew Kofron5, Paul F Lambert4, Adam Lane6,7, Najim Ameziane8, El Mustapha Bahassi2, Kathryn A Wikenheiser-Brokamp9,10, Alessandro de Alarcon11,12, David F Smith11,12,13, Susanne I Wells1,6.   

Abstract

Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is driven by human papillomavirus (HPV) low-risk strains and is associated with significant morbidity. While previous studies of 2D cultures have shed light on disease pathogenesis and demonstrated the utility of personalized medicine approaches, monolayer cultures lack the 3D tissue architecture and physiology of stratified, sequentially differentiated mucosal epithelium important in RRP disease pathogenesis. Herein we describe the establishment of JoRRP-derived primary cell populations that retain HPV genomes and viral gene expression in culture. These were directly compared to cells from matched adjacent non-diseased tissue, given the known RRP patient-to-patient variability. JoRRP papilloma versus control cells displayed decreased growth at subconfluency, with a switch to increased growth after reaching confluency, suggesting relative resistance to cell-cell contact and/or differentiation. The same papilloma cells grown as 3D organotypic rafts harbored hyperproliferation as compared to controls, with increased numbers of proliferating basal cells and inappropriately replicating suprabasal cells, mimicking phenotypes in the patient biopsies from which they were derived. These complementary model systems provide novel opportunities to elucidate disease mechanisms at distinct stages in JoRRP progression and to identify diagnostic, prognostic and therapeutic factors to personalize patient management and treatment.

Entities:  

Keywords:  3D organotypic rafts; JoRRP; low-risk HPV

Year:  2021        PMID: 33418959      PMCID: PMC7825105          DOI: 10.3390/v13010068

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  28 in total

Review 1.  Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.

Authors:  Sal Taliercio; Michelle Cespedes; Hayley Born; Ryan Ruiz; Scott Roof; Milan R Amin; Ryan C Branski
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-01       Impact factor: 6.223

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells.

Authors:  Frank A Suprynowicz; Geeta Upadhyay; Ewa Krawczyk; Sarah C Kramer; Jess D Hebert; Xuefeng Liu; Hang Yuan; Chaitra Cheluvaraju; Phillip W Clapp; Richard C Boucher; Christopher M Kamonjoh; Scott H Randell; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

4.  Use of reprogrammed cells to identify therapy for respiratory papillomatosis.

Authors:  Hang Yuan; Scott Myers; Jingang Wang; Dan Zhou; Jennifer A Woo; Bhaskar Kallakury; Andrew Ju; Michael Bazylewicz; Yvonne M Carter; Christopher Albanese; Nazaneen Grant; Aziza Shad; Anatoly Dritschilo; Xuefeng Liu; Richard Schlegel
Journal:  N Engl J Med       Date:  2012-09-27       Impact factor: 91.245

Review 5.  Recurrent respiratory papillomatosis.

Authors:  R A Tasca; R W Clarke
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

6.  Reliability of a staging assessment system for recurrent respiratory papillomatosis.

Authors:  Ryan P Hester; Craig S Derkay; Bonnie L Burke; M Louise Lawson
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-05       Impact factor: 1.675

Review 7.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

8.  Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; William L Valentino; Nicole Ruszkay; Evan Powell; Craig S Derkay; Riaz Y Seedat; Virgilijus Uloza; Frederik G Dikkers; David E Tunkel; Sukgi S Choi; Anthony J Mortelliti; Paolo Campisi; Juan C Ospina; Adam J Donne; Robert T Sataloff; Stephen F Conley; John E McClay; Ellen M Friedman; Lisa Elden; Dale A Tylor; Clark A Rosen; Libby J Smith; Graeme J Copley; David E Karas; John M Schweinfurth; Charles M Myer; Brian J Wiatrak; Joseph E Dohar; Steven E Sobol; Robert W Bastian; Richard J H Smith; Marshall E Smith; Abebe M Wassie; James C Post; Garth D Ehrlich
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

9.  Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis.

Authors:  Julie Ahn; Justin A Bishop; Belinda Akpeng; Sara I Pai; Simon R A Best
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-08-13       Impact factor: 1.547

10.  Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Authors:  Turid Omland; Kathrine A Lie; Harriet Akre; Lars Erik Sandlie; Peter Jebsen; Leiv Sandvik; Dag Andre Nymoen; Davit Bzhalava; Joakim Dillner; Kjell Brøndbo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more
  4 in total

1.  Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1.

Authors:  Renee E King; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

2.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

3.  HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening.

Authors:  Mary C Bedard; Alessandro de Alarcon; Yann-Fuu Kou; David Lee; Alexandra Sestito; Angela L Duggins; Marion Brusadelli; Adam Lane; Kathryn A Wikenheiser-Brokamp; Susanne I Wells; David F Smith
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

4.  Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal Papilloma.

Authors:  Taro Ikegami; Hitoshi Hirakawa; Narutoshi Tsukahara; Akikazu Murakami; Norimoto Kise; Asanori Kiyuna; Takayoshi Kosugi; Shinya Agena; Hidetoshi Kinjyo; Narumi Hasegawa; Masatomo Touyama; Shunsuke Kondo; Hiroyuki Maeda; Mikio Suzuki; Akira Ganaha
Journal:  Microorganisms       Date:  2021-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.